Expression of transmembrane protein 41A is associated with metastasis via the modulation of E‑cadherin in radically resected gastric cancer

Lin,Bin; Xue,Yingming; Qi,Chao; Chen,Xiangjie; Mao,Weizheng

doi:10.3892/mmr.2018.9241

Expression of transmembrane protein 41A is associated with metastasis via the modulation of E‑cadherin in radically resected gastric cancer

Authors:
- Bin Lin
- Yingming Xue
- Chao Qi
- Xiangjie Chen
- Weizheng Mao
View Affiliations

Affiliations: Department of General Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, Shandong 266071, P.R. China, Department of General Surgery, Dalian Medical University, Dalian, Liaoning 116044, P.R. China
Published online on: July 3, 2018 https://doi.org/10.3892/mmr.2018.9241
Pages: 2963-2972

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) is one of the most commonly occurring malignancies worldwide, and metastasis is one of the key processes affecting the prognosis of GC. TMEM41A, which belongs to a group of transmembrane proteins that participate in signaling pathways and tumor development, is a 264‑amino acid protein encoded by a gene mapped to human chromosome The exact role of TMEM41A in GC has not been determined to date. In the present study, the expression of TMEM41A in 147 cases of GC was analyzed with immunohistohemistry and the prognoses of these patients were analyzed. It was revealed that TMEM41A was highly expressed in GC tissues, and may be associated with the progression of GC and poor prognosis. The expression of TMEM41A was observed to be correlated with lymph node metastasis, distant metastasis and advanced tumor, node and metastasis stages. Knockdown of TMEM41A in vitro and in vivo decreased the GC cell migration ability by regulating epithelial‑to‑mesenchymal transition and cell autophagy, via the upregulation of E‑cadherin and downregulating N‑cadherin expression in GC cells by reverse transcription‑quantitative polymerase chain reaction (PCR), semi‑PCR and western blotting. Furthermore, TMEM41A upregulation was associated with the upregulation of p62 and altered the conversion of light chain (LC)3‑1 into LC3‑2 by western blotting. Knockdown of TMEM41A was also observed to affect tumor metastasis in nude mice. Therefore, TMEM41A may be considered as a novel therapeutic target for the treatment of GC‑associated metastasis.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Yuan DD, Zhu ZX, Zhang X and Liu J: Targeted therapy for gastric cancer: Current status and future directions (Review). Oncol Rep. 35:1245–1254. 2016. View Article : Google Scholar : PubMed/NCBI
3	Jin X, Zhu Z and Shi Y: Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis. Bull Cancer. 101:E1–E12. 2014.PubMed/NCBI
4	Valastyan S and Weinberg RA: Tumor metastasis: Molecular insights and evolving paradigms. Cell. 147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
5	Bates RC and Mercurio AM: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
6	Ferrera L, Caputo A and Galietta LJ: TMEM16A protein: A new identity for Ca(2+)-dependent Cl- channels. Physiology (Bethesda). 25:357–363. 2010.PubMed/NCBI
7	Zeng X, Huang P, Chen M, Liu S, Wu N, Wang F and Zhang J: TMEM16A regulates portal vein smooth muscle cell proliferation in portal hypertension. Exp Ther Med. 15:1062–1068. 2018.PubMed/NCBI
8	Zhang X, Zhang Y, Miao Y, Zhou H, Jiang G and Wang E: TMEM17 depresses invasion and metastasis in lung cancer cells via ERK signaling pathway. Oncotarget. 8:70685–70694. 2017.PubMed/NCBI
9	Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
10	Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, et al: Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA. 99:16899–16903. 2002. View Article : Google Scholar : PubMed/NCBI
11	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
12	Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S and Boiocchi M: Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53:5775–5779. 1993.PubMed/NCBI
13	Ricciardi R, Burks E, Schoetz DJ, Verma Y, Kershnar E, Kilpatrick MW, Tsipouras P and Walat RJ: Is there a gain in chromosome 3q in the pathway to anal cancer? Dis Colon Rectum. 57:1183–1187. 2014. View Article : Google Scholar : PubMed/NCBI
14	Wu CL, Sloan P, Read AP, Harris R and Thakker N: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res. 54:6484–6488. 1994.PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Feng X, Zhu K, Liu J, Chen J, Tang J, Liang Y, Jin R, Liang X and Cai X: The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy. Onco Targets Ther. 9:3213–3221. 2016.PubMed/NCBI
17	Kumar R, Vadlamudi RK and Adam L: Apoptosis in mammary gland and cancer. Endocr Relat Cancer. 7:257–269. 2000. View Article : Google Scholar : PubMed/NCBI
18	Qinghai Z, Yanying W, Yunfang C, Xukui Z and Xiaoqiao Z: Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene. 537:328–332. 2014. View Article : Google Scholar : PubMed/NCBI
19	Park S, Ha S, Kwon HW, Kim WH, Kim TY, Oh DY, Cheon GJ and Bang YJ: Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: Association and clinical implication. J Nucl Med. 58:899–904. 2017. View Article : Google Scholar : PubMed/NCBI
20	Zeng X, Huang P, Chen M, Liu S, Wu N, Wang F and Zhang J: TMEM16A regulates portal vein smooth muscle cell proliferation in portal hypertension. Exp Ther Med. 15:1062–1068. 2018.PubMed/NCBI
21	Han Z, Wang T, Han S, Chen Y, Chen T, Jia Q, Li B, Li B, Wang J, Chen G, et al: Low-expression of TMEM100 is associated with poor prognosis in non-small-cell lung cancer. Am J Transl Res. 9:2567–2578. 2017.PubMed/NCBI
22	Ou D, Yang H, Hua D, Xiao S and Yang L: Novel roles of TMEM100: Inhibition metastasis and proliferation of hepatocellular carcinoma. Oncotarget. 6:17379–17390. 2015. View Article : Google Scholar : PubMed/NCBI
23	Al-Hussain T, Ali A and Akhtar M: Wilms tumor: An update. Adv Anat Pathol. 21:166–173. 2014. View Article : Google Scholar : PubMed/NCBI
24	Haga Y, Hiroshima K, Iyoda A, Kohno H, Shibuya K, Iizasa T, Fujisawa T and Ohwada H: Frequency of loss of heterozygosity at 3 p, 9 p, 13 q and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer. Thorac Cardiovasc Surg. 53:114–117. 2005. View Article : Google Scholar : PubMed/NCBI
25	Calin GA and Croce CM: MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 25:6202–6210. 2006. View Article : Google Scholar : PubMed/NCBI
26	Calvo SE, Pagliarini DJ and Mootha VK: Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci USA. 106:7507–7512. 2009. View Article : Google Scholar : PubMed/NCBI
27	Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 33 Suppl:S245–S254. 2003. View Article : Google Scholar
28	Fahrner JA, Eguchi S, Herman JG and Baylin SB: Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62:7213–7282. 2002.PubMed/NCBI
29	Prieto-García E, Díaz-García CV, García-Ruiz I and Agulló-Ortuño MT: Epithelial-to-mesenchymal transition in tumor progression. Med Oncol. 34:1222017. View Article : Google Scholar : PubMed/NCBI
30	Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Pretet JL, Soussan P, Polette M, Saint Lacau Guily J and Birembaut P: Papillophar Study Group: Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: The papillophar study. Br J Cancer. 116:362–369. 2017. View Article : Google Scholar : PubMed/NCBI
31	Wang Y and Zhou BP: Epithelial-mesenchymal transition-A hallmark of breast cancer metastasis. Cancer Hallm. 1:38–49. 2013. View Article : Google Scholar : PubMed/NCBI
32	Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL and Weinberg RA: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 145:926–940. 2011. View Article : Google Scholar : PubMed/NCBI
33	Zhao Y, Guo Q, Chen J, Hu J, Wang S and Sun Y: Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation. Oncol Rep. 31:358–364. 2014. View Article : Google Scholar : PubMed/NCBI
34	Fu M, Huang Z, Zang X, Pan L, Liang W, Chen J, Qian H, Xu W, Jiang P and Zhang X: Long noncoding RNA LINC00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer. Cell Prolif. 2018. View Article : Google Scholar
35	Gugnoni M, Sancisi V, Manzotti G, Gandolfi G and Ciarrocchi A: Autophagy and epithelial-mesenchymal transition: An intricate interplay in cancer. Cell Death Dis. 7:e25202016. View Article : Google Scholar : PubMed/NCBI
36	Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, Song Z, Zheng Q and Xiong J: Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis. 34:1343–1351. 2013. View Article : Google Scholar : PubMed/NCBI
37	Lv Q, Wang W, Xue J, Hua F, Mu R, Lin H, Yan J, Lv X, Chen X and Hu ZW: DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res. 72:3238–3250. 2012. View Article : Google Scholar : PubMed/NCBI
38	Catalano M, D'Alessandro G, Lepore F, Corazzari M, Caldarola S, Valacca C, Faienza F, Esposito V, Limatola C, Cecconi F and Di Bartolomeo S: Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells. Mol Oncol. 9:1612–1625. 2015. View Article : Google Scholar : PubMed/NCBI